Suppr超能文献

眼内动脉化疗治疗视网膜母细胞瘤:剂量学影响。

Intra-arterial chemotherapy for retinoblastoma: the dosimetric impact.

机构信息

Department of Medical Physics, Azienda USL Toscana sud est, Siena, Italy.

Unit of Neuroimaging and Neurointervention, Azienda Ospedaliera Universitaria Senese, Siena, Italy.

出版信息

Neuroradiology. 2019 Sep;61(9):1083-1091. doi: 10.1007/s00234-019-02260-7. Epub 2019 Jul 22.

Abstract

PURPOSE

Purposes are (1) to measure main radiation parameters and (2) to propose a method to estimate the absorbed doses of internal organs starting from DAP values. Measuring the exposition of internal organs by repeated irradiations on an anthropomorphic phantom with the same settings used in vivo, we could establish correlations between (1) DAP and the dose recorded by a dosimeter placed along the X-ray beam entrance pathway; (2) the dose recorded by the same dosimeter and the absorbed dose in internal organs.

METHODS

Forty-four consecutive patients (16 males, 28 females) (mean age 35.4 months) treated at our institution with IAC (216 procedures: 196 via the ICA and 20 into branches of the ECA) were included in this prospective study. IAC was divided into 5 phases. Fluoroscopic time, DAP, and ESD were measured.

RESULTS

The mean DAP was 595 ± 445 cGy cm and the mean fluoroscopic time was 540 ± 403 s. ESD was on average 9.59 mGy (range 0.8-165 mGy). The absorbed dose was lower than 12.1 mGy in the left retina (the more exposed organ) in 75% of single treatments and lower than 25 mGy in 95% of treatments. In the cases of 3 and 6 sessions, the left retina of 75% of patients absorbed respectively less than 36.3 and 72.7 mGy, whereas the left retina of 95% of patients received less than 75.2 and 150.4 mGy. Other organs were less exposed.

CONCLUSION

This paper describes a method of absorbed dose estimation providing ranges used clinically in a single practice and the basis for further prospective studies.

摘要

目的

(1)测量主要辐射参数,(2)提出一种从 DAP 值估算内部器官吸收剂量的方法。通过对具有与体内相同设置的人体模型进行多次照射,测量内部器官的曝光量,我们可以建立(1)DAP 与放置在 X 射线束入口路径中的剂量计记录的剂量之间的关系;(2)同一剂量计记录的剂量与内部器官吸收剂量之间的关系。

方法

本前瞻性研究纳入了在我院接受 IAC 治疗的 44 例连续患者(16 名男性,28 名女性;平均年龄 35.4 个月)(216 例 IAC 治疗:196 例经 ICA,20 例进入 ECA 分支)。将 IAC 分为 5 个阶段。测量透视时间、DAP 和 ESD。

结果

平均 DAP 为 595±445 cGy·cm,平均透视时间为 540±403 s。ESD 平均为 9.59 mGy(范围 0.8-165 mGy)。单次治疗中,75%的左视网膜(暴露较多的器官)吸收剂量低于 12.1 mGy,95%的治疗中吸收剂量低于 25 mGy。在 3 次和 6 次治疗的情况下,75%的患者左视网膜分别吸收的剂量小于 36.3 和 72.7 mGy,而 95%的患者左视网膜吸收的剂量小于 75.2 和 150.4 mGy。其他器官的暴露量较低。

结论

本文描述了一种吸收剂量估算方法,提供了单一实践中临床使用的范围,并为进一步的前瞻性研究提供了依据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验